Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2005
12/14/2005EP1604688A1 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy
12/14/2005EP1604682A1 Gonadal function improving agents
12/14/2005EP1604681A1 Use of botulinum toxin in the treatment of joint pain
12/14/2005EP1604680A1 Use of botulinum toxin in the treatment of neuralgia pain
12/14/2005EP1604679A1 Use of botulinum toxin in the treatment of visceral pain
12/14/2005EP1604678A1 Use of botulinum toxin in the treatment of post-operative pain
12/14/2005EP1604677A1 Composition having antioxidant, anti-inflammatory, and immunostimulant actions
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604656A1 Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1604032A2 Method for detecting prognosis of cancer
12/14/2005EP1604024A1 Methods of using growth factors for treating heart disease
12/14/2005EP1604022A2 Modulation of gene expression using dna-rna hybrids
12/14/2005EP1604014A2 Gene expression in breast cancer
12/14/2005EP1604010A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies
12/14/2005EP1603947A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1)
12/14/2005EP1603946A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
12/14/2005EP1603945A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
12/14/2005EP1603944A1 Amylin aggregation inhibitors and use thereof
12/14/2005EP1603943A2 Methods and compositions involving mda-7
12/14/2005EP1603942A2 Regulation of gene expression
12/14/2005EP1603937A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
12/14/2005EP1603596A1 Liquid formulations of tumor necrosis factor-binding proteins
12/14/2005EP1603589A1 Delivery system for drug and cell therapy
12/14/2005EP1603588A2 Stabilisation of growth hormones in solution
12/14/2005EP1603587A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis
12/14/2005EP1603586A1 14-3-3 protein for prevention and treatment of fibroproliferative disorders
12/14/2005EP1603585A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
12/14/2005EP1603584A1 Aplidine for multiple myeloma treatment
12/14/2005EP1603560A1 Topical immunotherapy and compositions for use therein
12/14/2005EP1603542A1 Treatment and/or prevention of non-viral epithelial damage
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1603530A1 Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis
12/14/2005EP1603512A2 Novel cyclosporins
12/14/2005EP1603450A2 Type 1 ryanodine receptor-based methods
12/14/2005EP1603392A2 Paclitaxel hybrid derivatives
12/14/2005EP1603391A1 Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
12/14/2005EP1599715A3 Autologous or homologous coagulant produced from anticoagulated whole blood
12/14/2005EP1543324A4 Methods and compositions for grafting functional loops into a protein
12/14/2005EP1482969A4 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/14/2005EP1296742B1 Intradermal delivery of substances
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1263968B1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release
12/14/2005EP1177292B1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
12/14/2005EP1159413A4 Secreted proteins and uses thereof
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1091975B1 Novel cyclosporin with improved activity profile
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1080198B1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005EP0956036B1 Anti-fibrotic agent assay
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005EP0920504B1 Class e voltage-gated calcium channel antagonist and methods
12/14/2005EP0858504B1 Diagnostics and treatments of periodontal disease
12/14/2005EP0831782B1 Methods and system for processing dispersible fine powders
12/14/2005CN1708514A Hydroxyalkyl starch derivatives
12/14/2005CN1708513A Ocular gene therapy
12/14/2005CN1708315A Anti-tumor combinations comprising proteins and chemotherapeutics
12/14/2005CN1708297A Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents
12/14/2005CN1708293A S1p receptor agonist for treating demyelinate disease
12/14/2005CN1706955A Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF
12/14/2005CN1706493A Application of human urokinase-type peptidase in preparing medicine for treating pulmonary hypertension
12/14/2005CN1706492A Human liver cancer suppressor gene LLCI and the application of its coding protein
12/14/2005CN1706491A Human liver cancer related gene and the application of its coding protein
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231584C Cell proliferation factor Fwap 10576
12/14/2005CN1231496C Human protein with cancer cell growth suppressing function and its coding sequence
12/14/2005CN1231495C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses
12/14/2005CN1231494C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and application in medicine
12/14/2005CN1231493C Amphoteric sterols and the use thereof
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/14/2005CN1231261C Compound alliin enteric solubility capsule
12/14/2005CN1231260C Hemostatic
12/14/2005CN1231258C Interferon lozenge ice block and making method and use thereof
12/14/2005CN1231257C Use of preparing medicine for raising genitality of female animals with long PENTRAXIN PTX 3
12/14/2005CN1231256C Non-aqueous proton peptide formulations
12/14/2005CN1231208C Pharmaceutical compositions
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974867 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974859 oligopeptide having dental caries protective properties; administering by mouthwash, chewing gum or toothpaste
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974800 Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor
12/13/2005US6974799 Compositions containing mixtures of tetrapeptides and tripeptides
12/13/2005US6974798 Involving neuronal damage, loss, or degeneration, such as of vestibular ganglion neurons, by administration of a tyrosine kinase-containing receptor (trk) trkB or trkC agonist such as a neurotrophin; treating ototoxicity
12/13/2005US6974797 Bactericides for drug resistant bacteria
12/13/2005US6974796 Therapeutic compositions for treatment of a damaged tissue
12/13/2005US6974795 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
12/13/2005US6974794 trolox bound to hemoglobin; biocompatible oxygen transporting molecules coupled with antioxidants; for protection of red blood cells (RBCs) against lysis.
12/13/2005US6974793 Method for treating primary hyperparathyroid disorders
12/13/2005US6974792 Alpha 1-antitrypsin preparation as well as a method for producing the same
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
1 ... 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 ... 3163